Paas-Rozner M - Search Results

1

Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.

Zisman E, Katz-Levy Y, Dayan M, Kirshner SL, Paas-Rozner M, Karni A, Abramsky O, Brautbar C, Fridkin M, Sela M, Mozes E. Zisman E, et al. Among authors: paas rozner m. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4492-7. doi: 10.1073/pnas.93.9.4492. Proc Natl Acad Sci U S A. 1996. PMID: 8633096 Free PMC article. Clinical Trial.

2

A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells.

Paas-Rozner M, Sela M, Mozes E. Paas-Rozner M, et al. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6676-81. doi: 10.1073/pnas.1131898100. Epub 2003 May 12. Proc Natl Acad Sci U S A. 2003. PMID: 12743364 Free PMC article.

3

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses.

Katz-Levy Y, Paas-Rozner M, Kirshner S, Dayan M, Zisman E, Fridkin M, Wirguin I, Sela M, Mozes E. Katz-Levy Y, et al. Among authors: paas rozner m. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3200-5. doi: 10.1073/pnas.94.7.3200. Proc Natl Acad Sci U S A. 1997. PMID: 9096370 Free PMC article.

4

Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor.

Karni A, Zisman E, Katz-Levy Y, Paas-Rozner M, Dayan M, Brautbar C, Abramsky O, Sela M, Mozes E. Karni A, et al. Among authors: paas rozner m. Neurology. 1997 Jun;48(6):1638-42. doi: 10.1212/wnl.48.6.1638. Neurology. 1997. PMID: 9191780

5

Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes.

Faber-Elmann A, Paas-Rozner M, Sela M, Mozes E. Faber-Elmann A, et al. Among authors: paas rozner m. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14320-5. doi: 10.1073/pnas.95.24.14320. Proc Natl Acad Sci U S A. 1998. PMID: 9826698 Free PMC article.

6

Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.

Paas-Rozner M, Dayan M, Paas Y, Changeux JP, Wirguin I, Sela M, Mozes E. Paas-Rozner M, et al. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2168-73. doi: 10.1073/pnas.040554597. Proc Natl Acad Sci U S A. 2000. PMID: 10681457 Free PMC article.

7

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.

Paas-Rozner M, Sela M, Mozes E. Paas-Rozner M, et al. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12642-7. doi: 10.1073/pnas.221456798. Epub 2001 Oct 16. Proc Natl Acad Sci U S A. 2001. PMID: 11606745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters